UltraSPECT signs multi-year deal with UPPI

Twitter icon
Facebook icon
LinkedIn icon
e-mail icon
Google icon
UltraSPECT, a developer of nuclear medicine image reconstruction technology, has signed a multi-year distribution agreement with nuclear pharmacy network UPPI for the exclusive leasing and/or non-exclusive sale of its cardiac and bone imaging applications in the U.S.

The Auburndale, Mass.-based company said the product line utilizes its Wide-Beam Reconstruction (WBR) technology that seeks to enhance the performance of gamma cameras and PET scanners.